Patents
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
04/2012
04/26/2012WO2011149909A3 Class i mhc phosphopeptides for cancer immunotherapy and diagnosis
04/26/2012WO2011147797A3 Hybrid compound, the use thereof, and method for the production thereof
04/26/2012WO2011119008A3 Peptides for promoting angiogenesis and an use thereof
04/26/2012WO2011112100A8 Peptide material, feed composition and preparations and uses thereof
04/26/2012WO2011089396A3 Pyruvamide compounds as inhibitors of dust mite group 1 peptidase allergen
04/26/2012WO2009089620A8 Protein c rs2069915 as a response predictor to survival and administration of activated protein c or protein c-like compound
04/26/2012WO2009046464A8 Articular cartilage gene therapy with recombinant vector encoding bmp-7
04/26/2012US20120101535 Bone repair putty
04/26/2012US20120101427 Novel photosensitizer formulations for oral administration
04/26/2012US20120101325 Locally targeted anti-fibrotic agents and methods of use
04/26/2012US20120101154 Compositions and methods for increasing compliance with therapies using aldehyde dehydrogenase inhibitors and treating alcoholism
04/26/2012US20120101050 Compounds for enzyme inhibition
04/26/2012US20120101049 Pharmaceutical Composition Of A Potent HCV Inhibitor For Oral Administration
04/26/2012US20120101048 Compounds for enzyme inhibition
04/26/2012US20120101047 Peptidomimetic macrocycles
04/26/2012US20120101046 Prophylactic or therapeutic agent for retinal disease and method for prophylaxis or therapy of retinal disease using jnk (c-jun amino-terminal kinase) - inhibitory peptide, and use of the peptide
04/26/2012US20120101045 TRANSDUCIBLE DELIVERY OF NUCLEIC ACIDS USING MODIFIED dsRNA BINDING DOMAINS
04/26/2012US20120101044 Gold (iii) complexes with oligopeptides functionalized with sulfur donors and use thereof as antitumor agents
04/26/2012US20120101043 Delta-opioid receptor selective analgesics
04/26/2012US20120101042 Agents and Methods for Tissue Repair and Regeneration
04/26/2012US20120101041 Polyionic dendrimer and hydrogel comprising same
04/26/2012US20120101040 angiogenesis inducing agent comprising recombinant gelatin
04/26/2012US20120101039 Calcium-sensing receptor-active compounds
04/26/2012US20120101038 Use of glp-1, glp-1 derivatives or glp-1 fragments for skin regeneration, stimulation of hair growth, or treatment of diabetes
04/26/2012US20120101037 Glucose-dependent insulinotropic peptide analogs
04/26/2012US20120101036 Novel cellular factor-containing solution compositions
04/26/2012US20120101035 VEGF Antagonist Formulations
04/26/2012US20120101034 Process for solubilizing glucagon-like peptide 1 compounds
04/26/2012US20120101033 Retinitis pigmentosa treatment
04/26/2012US20120101032 Novel macrocyclic inhibitors of hepatitis c virus replication
04/26/2012US20120101031 Macrocyclic hepatitis c serine protease inhibitors
04/26/2012US20120101030 Caspofungin Composition
04/26/2012US20120101029 Compositions comprising semaphorins for the treatment of angiogenesis related diseases and methods of selection thereof
04/26/2012US20120101028 Anti-inflammatory compounds and uses thereof
04/26/2012US20120101027 Inhibition of secretion from non-neuronal cells
04/26/2012US20120101026 Compounds For Enzyme Inhibition
04/26/2012US20120101025 Compounds For Enzyme Inhibition
04/26/2012US20120101024 Methods and Compositions for Differentiating Embryonic Stem Cells
04/26/2012US20120101023 Method of diagnosing bladder cancer
04/26/2012US20120101022 Self-assembling peptides bearing organic electronic functionality and applications employing the same
04/26/2012US20120101021 Compositions, formulations and methods of treating preeclampsia-type disorders of pregnancy
04/26/2012US20120101006 Methods and Compositions for the Production of Orthogonal tRNA-Aminoacyl tRNA Synthetase Pairs
04/26/2012US20120100229 Treatment and Prevention of White Matter Injury with KATP Channel Activators
04/26/2012US20120100225 Osteoinductive bone graft injectable cement
04/26/2012US20120100224 Compositions Against Rotavirus Infection and Processes For Producing The Same
04/26/2012US20120100217 Polymeric material
04/26/2012US20120100215 Muller stem cells
04/26/2012US20120100210 Composition for the administration of polymeric drugs
04/26/2012US20120100205 Components for producing amphoteric liposomes
04/26/2012US20120100187 Coatings and methods for controlled elution of hydrophilic active agents
04/26/2012US20120100186 Nanoparticulate-based contraceptive/anti-hiv composition and methods
04/26/2012US20120100185 Regeneration of tissue without cell transplantation
04/26/2012US20120100182 Continuous Cell Programming Devices
04/26/2012US20120100166 Ang-2 Binding Complexes and Uses Thereof
04/26/2012US20120100155 Pharmaceutical agent
04/26/2012US20120100149 Injectable, Non-Aqueous Suspension with High Concentration of Therapeutic Agent
04/26/2012US20120100136 Methods for treating or preventing ophthalmological diseases
04/26/2012US20120100128 Methods of and compositions for inhibiting the proliferation of mammalian cells
04/26/2012US20120100127 Method to Increase the Absorption of Unsaturated Fatty Acids by Human Infants
04/26/2012US20120100126 Method to Increase the Growth Velocity of Human Infants
04/26/2012US20120100125 Local dehydration for carpal tunnel syndrome
04/26/2012US20120100124 Methods for determining the oncogenic condition of cell, uses thereof, and methods for treating cancer
04/26/2012US20120100123 Compositions and methods for the prevention of cardiovascular disease
04/26/2012US20120100122 Combination therapy
04/26/2012US20120100121 Pegylated L-Asparaginase
04/26/2012US20120100116 Neuron generation, regeneration and protection
04/26/2012US20120100112 Materials and methods for using adipose stem cells to treat lung injury and disease
04/26/2012US20120100106 Collagen-binding synthetic peptidoglycans for wound healing
04/26/2012US20120100105 Agent and method for treating refractory chronic hepatitis c
04/26/2012US20120100104 Antiviral Compounds And Uses Thereof
04/26/2012US20120100103 In situ forming hydrogel and biomedical use thereof
04/26/2012US20120100101 Ctla-4 antibody dosage escalation regimens
04/26/2012US20120100100 Cyclin dependent kinase inhibitors and methods of use
04/26/2012US20120100099 Fusion proteins having mutated immunoglobulin hinge region
04/26/2012US20120100077 Mixture of amphipathic molecules and method for modifying cell membranes by means of fusion
04/26/2012US20120100076 Methods of modulating cold sensory perception
04/26/2012US20120100068 Anti-CD74 Immunoconjugates and Methods of Use
04/26/2012CA2815102A1 Wdhd1 peptides and vaccines including the same
04/26/2012CA2815100A1 C18orf54 peptides and vaccines including the same
04/26/2012CA2815030A1 Selective targeting of the cd40l/mac-1 interaction by small peptide inhibitors and its use for the treatment of inflammation and atherogenesis
04/26/2012CA2815000A1 Discovery of regulatory t cells programmed to suppress an immune response
04/26/2012CA2814967A1 Short peptides for enhancing muscle function
04/26/2012CA2814927A1 Compositions for drug administration
04/26/2012CA2812857A1 Method to increase the growth velocity of human infants
04/26/2012CA2812852A1 Method to increase the absorption of unsaturated fatty acids by human infants
04/26/2012CA2812785A1 Methods and compositions for modulating the wnt pathway
04/25/2012EP2444549A1 Textile materials with bioactive protection
04/25/2012EP2444499A2 Amino acid substituted molecules
04/25/2012EP2444424A1 Improved nanobodies TM for the treatment of aggregation-mediated disorders
04/25/2012EP2444411A1 Tripeptide boronic acid or boronic ester, preparative method and use thereof
04/25/2012EP2444410A2 Brachyury polypeptides and methods for use
04/25/2012EP2444409A2 Compositions and methods for the treatment of immune related diseases
04/25/2012EP2444105A1 Anti-gram-negative bacteria agent
04/25/2012EP2444102A1 Combination therapy for treating protein deficiency disorders
04/25/2012EP2444101A1 Selective targeting of the CD40L/Mac-1 interaction by small peptide inhibitors and its use for the treatment of inflammation and atherogenesis
04/25/2012EP2444100A2 Vaccine comprising Amb a 1 peptides for use in the treatment of ragweed allergy
04/25/2012EP2444099A1 Antibodies and related molecules that bind to 161P2F10B proteins
04/25/2012EP2444089A2 Anhydrous compositions useful for attaining enhanced sexual wellness
04/25/2012EP2444069A1 Controlled release compositions
04/25/2012EP2443257A1 Method of determining response to treatment with immunomodulatory composition